☰

PolfaTarchomin

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of PolfaTarchomin's published strategy and is not endorsed by, or produced in cooperation with, PolfaTarchomin. Company website

Strategic priorities

PolfaTarchomin operates across 4 stated priorities, with the most concrete near-term plan anchored on oncology leadership (oeb 5).

Building a 12,000 sqm Center for Development and Production of Highly Potent Drugs with capacity for 20 million vials and 6 million ampoules annually, operating at OEB 5 containment levels for oncology and immunosuppressive medications.

Maintaining Poland's largest antibiotic production capacity, producing approximately 10% of EU-classified critical medicines including penicillins, cephalosporins, and human insulins to ensure regional drug availability.

Transitioning from legacy manufacturing processes to state-of-the-art sterile production through capital investments, including a new parenteral laboratory performing 4,000+ tests annually launched in 2025.

Challenges we see

  • Operations Manufacturing

    Infrastructure Instability & Environmental Control Failures

    The coexistence of highly sensitive modern equipment and legacy utility infrastructure creates operational vulnerabilities. Multiple production facilities on a single 17-hectare campus increase complexity of maintaining consistent environmental conditions.

    The Elenium batch recall in late 2025, relating to an environmental control issue during an emergency power switch, points to areas for improvement in environmental monitoring and OT failover strategy.

  • Digital Integration

    Data Fragmentation Across 11 Production Facilities

    The company operates 11 different production facilities on the Warsaw campus, each likely with isolated PLC and SCADA systems. Laboratory Services generates 4,000+ tests annually with no unified data management system.

    Leadership lacks real-time, cross-facility visibility into production efficiency, energy consumption, and quality metrics—creating "Excel Islands" that slow decision-making.

  • Digital Integration

    IT/OT Convergence in Legacy Environment

    The transition toward Industry 4.0 requires bridging legacy PLCs, SCADA systems, and new IoT sensors in the OEB 5 facility. Different protocols and vendors create integration complexity.

    Cybersecurity risks grow as IT/OT networks converge without proper IEC 62443 and NIS2 compliance frameworks, particularly for legacy industrial systems.

  • Compliance Regulatory

    OEB 5 Containment & Worker Safety Compliance

    The new oncology plant operates at OEB 5 level requiring stringent containment protocols to protect workers from highly potent active pharmaceutical ingredients and prevent environmental contamination.

    Manual monitoring of hazardous HP compounds drives risks of exposure incidents and compliance gaps in real-time containment verification.

  • ESG Regulatory

    CSRD & ESG Reporting Burden

    From January 2025, large Polish companies must disclose detailed sustainability information under CSRD including carbon footprinting and energy efficiency metrics across all facilities.

    Manual collection of sustainability data across 11 energy-intensive facilities with sterilization processes creates significant operational burden and risks of compliance gaps.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Environmental Monitoring & Quality Failures

    The Elenium batch recall, relating to an environmental control issue, indicates that legacy facilities would benefit from real-time environmental anomaly detection. Quality issues during power transitions point to the value of automated failover monitoring.

    Deploy IoT environmental sensors with automated alert thresholds integrated into centralized dashboards to detect anomalies (temperature, humidity, pressure) before they cause batch losses.

  2. Cross-Facility Data Silos & Visibility Gap

    With 11 production facilities operating independently, leadership cannot access unified real-time data on production status, energy consumption, or critical medicine availability. Laboratory data from 4,000+ tests remains siloed.

    Implement an Industrial Data Platform that aggregates data from all facilities into a single source of truth, enabling real-time visibility and supporting the "National Drug Security" mandate.

  3. Laboratory Data Integrity & Automation

    The new parenteral laboratory performing 4,000+ tests annually likely captures data through manual paper notebooks or disconnected Excel spreadsheets, creating ALCOA+ compliance risks and "Digital Hesitancy."

    Deploy a Digital Lab solution with automated data pipelines that ingest results directly from lab equipment (Beckman Coulter, Roche) to ensure 100% data integrity for OEB 5 compliance.

  4. OEB 5 Worker Safety & Containment Monitoring

    Manual monitoring of highly potent compounds in the OEB 5 environment creates worker safety risks and compliance gaps. Traditional internal probes suffer from fouling in sterile environments.

    Implement non-invasive Computer Vision monitoring systems using external cameras to detect containment breaches, foam formation, and leakages without invasive probes.

  5. ESG Data Collection & CSRD Compliance

    Manual collection of energy, water, and carbon data across 11 facilities with energy-intensive sterilization processes creates significant burden and risk of non-compliance with CSRD requirements effective January 2025.

    Build an automated ESG data platform that captures sustainability metrics from facility systems in real-time, enabling automated CSRD reporting and positioning Polfa as "Green Leader" among state-owned enterprises.

What we'd propose

  • Digital CDMO

    IoT Environmental Resilience System

    Retrofit legacy production lines with smart environmental sensors to detect anomalies (condensation, temperature deviations, pressure changes) before they cause batch failures, ensuring production continuity during power transitions.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Enterprise AI

    Unified Industrial Data Platform

    Build an ontology-based data platform that aggregates production, quality, and energy data from all 11 Warsaw facilities into a single source of truth, enabling real-time visibility for leadership and supporting national drug security reporting.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Digital Lab

    Digital Lab for OEB 5 Facility

    Deploy a fully integrated Digital Lab solution for the new parenteral laboratory that automates data capture from analytical instruments, ensures ALCOA+ compliance, and accelerates bioequivalence studies for generic drug development.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    Computer Vision Containment Monitoring

    Engineer non-invasive visual monitoring systems for the OEB 5 oncology facility that use external cameras and AI algorithms to detect containment breaches, foam formation, and worker safety hazards without invasive probes.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Enterprise AI

    Automated ESG Compliance Platform

    Build an automated sustainability data collection system that captures energy, water, and carbon metrics across all 11 facilities in real-time, enabling CSRD compliance reporting and positioning Polfa as a sustainability leader.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what PolfaTarchomin's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration 25 → 80
11 facilities operate as data silos with no unified platform; 4,000+ tests captured in disconnected systems
Environmental Monitoring 30 → 85
Elenium recall points to opportunities in real-time anomaly detection; legacy lines are not yet equipped with smart sensors
Process Automation 50 → 90
New OEB 5 facility is highly automated, but legacy antibiotic lines rely on manual processes
Quality Management 45 → 90
Quality failures occurred despite cGMP compliance; reactive rather than predictive quality approach
Cybersecurity (OT) 30 → 80
Legacy PLCs/SCADA systems vulnerable; IT/OT convergence increases attack surface without IEC 62443
ESG Tracking 20 → 85
Manual sustainability data collection across energy-intensive facilities; CSRD deadline imminent

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with PolfaTarchomin, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].